CD8A and hepatocellular carcinoma: In addition, the frequency of PD1Hi cells in PD1+ CD8+ T cells in advanced stage HCC patients (stages II and III, n = 19) was two-fold higher than those in early stage (stage I, n = 11; P = 0.026; Fig. 1e).